Last reviewed · How we verify

NCT03225677

Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis

Recruiting now Last updated 1 December 2025
What this trial tests

trial testing blood draw and muscle biopsy in Cirrhosis in 20 participants. Currently enrolling.

Timeline
3 August 2017
Primary endpoint
30 September 2027
30 September 2027

Quick facts

Lead sponsorThe Cleveland Clinic
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment20
Start date3 August 2017
Primary completion30 September 2027
Estimated completion30 September 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Cirrhosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the rate and mechanisms of skeletal muscle protein synthesis and breakdown in cirrhotic patients by using multiple tracers and single muscle biopsies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cirrhosis

Currently open trials in the same condition.

Other The Cleveland Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03225677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing